ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$6.69
+0.25 (+3.88%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+21.7% upside
Low Target
$7.28
Average Target
$8.14
High Target
$10.62
Current Price
$6.69
Current
$6.69
$6.69
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Scenario Analysis
Bear Case
$7.28
8.8%
Low target
Base Case
$8.14
+21.7%
Avg target
Bull Case
$10.62
+58.7%
High target
Risk/Reward
6.7x
Highly favorable
Price in Context
52-Week High
$7.75
-13.7% from high
52-Week Low
$1.47
+355.1% from low
Target vs 52W High
$8.14
+5.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |